Andrew Cuomo promised to empower poor communities – but who will reap the financial benefits of cannabis legalization?
We exposed Nick Sinatra’s $1.2 million in back taxes earlier this year. The developer just got millions of dollars in subsidies to build in Canalside, even though he’s behind on his taxes again.
Several prominent Buffalo real estate developers have been quietly bringing in millions of dollars from leases to the agencies executing Trump’s brutal policies at the border.
Nick Sinatra owes at least $827,382.80 on 42 properties in Erie County. He has received nearly $1.5 million in public subsidies.
Despite a campus commitment to sustainability and a growing push for divestment, the University at Buffalo Foundation maintains investments in fracking-focused private equity funds.
Nick Sinatra is a young developer who has quickly amassed a huge portfolio of buildings in Buffalo, driving waves of gentrification in the process. We looked at the billionaire investors behind his operation.
Former Buffalo Police Commissioner Daniel Derenda (center) with Mayor Byron Brown via City of Buffalo . Daniel Derenda, who recently resigned as the commissioner of the Buffalo Police Department after holding that position for nearly eight years, has been hired by G4S Secure Solutions, the American subsidiary of G4S, a British private security firm. G4S, …
Rep. Chris Collins has at least $3 million invested with Buffalo developer Nick Sinatra. Now he is pushing Sinatra’s brother for a federal judgeship.
The protest at Delaware North headquarters highlighted Jeremy Jacobs’ ties to ICE in Buffalo. But the Delaware North empire stretches far beyond western New York.
Rep. Chris Collins, a Donald Trump ally under investigation by the Office of Congressional Ethics, loses millions as Innate Immunotherapeutics’ Stock Collapses.
Members of the Buffalo’s power elite are being questioned over their investments in Innate Immunotherapeutics, the Australian pharmaceutical company where Rep. Chris Collins is the top shareholder.
Insys Therapeutics made millions off of feeding the opioid crisis. Now it seeks to profit off of treating opiod addiction.